Shuyan Gu

1.8k total citations
72 papers, 1.1k citations indexed

About

Shuyan Gu is a scholar working on Endocrinology, Diabetes and Metabolism, General Health Professions and Economics and Econometrics. According to data from OpenAlex, Shuyan Gu has authored 72 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Endocrinology, Diabetes and Metabolism, 17 papers in General Health Professions and 11 papers in Economics and Econometrics. Recurrent topics in Shuyan Gu's work include Diabetes Treatment and Management (16 papers), Global Health Care Issues (9 papers) and Diabetes Management and Research (7 papers). Shuyan Gu is often cited by papers focused on Diabetes Treatment and Management (16 papers), Global Health Care Issues (9 papers) and Diabetes Management and Research (7 papers). Shuyan Gu collaborates with scholars based in China, United States and Hong Kong. Shuyan Gu's co-authors include Hengjin Dong, Xuemei Zhen, Xueshan Sun, Xiaoqian Hu, Yuxuan Gu, Cecilia Stålsby Lundborg, Huimei Hu, Yuanyuan Li, Lizheng Shi and Jingming Wei and has published in prestigious journals such as PLoS ONE, Physical Review B and Journal of Agricultural and Food Chemistry.

In The Last Decade

Shuyan Gu

65 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuyan Gu China 18 190 164 153 141 120 72 1.1k
Sayeeda Rahman United Kingdom 15 163 0.9× 119 0.7× 77 0.5× 163 1.2× 152 1.3× 55 1.5k
Xuemei Zhen China 15 121 0.6× 32 0.2× 61 0.4× 168 1.2× 244 2.0× 46 970
Yusra Habib Khan Pakistan 21 164 0.9× 116 0.7× 279 1.8× 220 1.6× 22 0.2× 136 1.8k
Tauqeer Hussain Mallhi Pakistan 20 168 0.9× 103 0.6× 303 2.0× 194 1.4× 22 0.2× 136 1.8k
Yuxuan Gu China 14 175 0.9× 34 0.2× 66 0.4× 78 0.6× 57 0.5× 58 800
Javed Akram Pakistan 25 184 1.0× 104 0.6× 159 1.0× 588 4.2× 30 0.3× 84 2.2k
Laurent Molinier France 18 156 0.8× 33 0.2× 37 0.2× 84 0.6× 204 1.7× 66 1.2k
Scott H. Podolsky United States 19 218 1.1× 22 0.1× 41 0.3× 234 1.7× 73 0.6× 73 1.7k
H. Kalter United States 27 336 1.8× 43 0.3× 207 1.4× 136 1.0× 35 0.3× 78 1.8k
Susan Mayor United Kingdom 15 270 1.4× 75 0.5× 35 0.2× 89 0.6× 16 0.1× 434 1.4k

Countries citing papers authored by Shuyan Gu

Since Specialization
Citations

This map shows the geographic impact of Shuyan Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuyan Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuyan Gu more than expected).

Fields of papers citing papers by Shuyan Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuyan Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuyan Gu. The network helps show where Shuyan Gu may publish in the future.

Co-authorship network of co-authors of Shuyan Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Shuyan Gu. A scholar is included among the top collaborators of Shuyan Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuyan Gu. Shuyan Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Yang, Feng, Xun Xu, Shuyan Gu, et al.. (2024). A Virulence Factor from Sclerotinia sclerotiorum Targets the Host Chloroplast Proteins to Promote Infection. Plants. 13(23). 3430–3430. 1 indexed citations
4.
Li, Shuo, Shuyan Gu, Xin Su, et al.. (2024). The Degradation of Rhodamine B by an Electro-Fenton Reactor Constructed with Gas Diffusion Electrode and Heterogeneous CuFeO@C Particles. Water. 16(20). 2906–2906. 1 indexed citations
5.
Gu, Shuyan, et al.. (2023). The effects of community-based home health care on the physical and mental health of older adults with chronic diseases. Quality of Life Research. 33(3). 691–703. 3 indexed citations
6.
Xu, Biao, et al.. (2023). Heuristics in vaccination Decision-Making for newly developed Vaccines: Understanding the public's imitative behavior. Preventive Medicine Reports. 37. 102548–102548.
7.
Bai, Lan, Shuyan Gu, Hai Gu, et al.. (2021). The Impact of Disability on Intergenerational Care Needs of the Elderly in China. INQUIRY The Journal of Health Care Organization Provision and Financing. 58. 2846612011–2846612011. 15 indexed citations
8.
Sun, Xueshan, Xuemei Zhen, Xiaoqian Hu, et al.. (2021). Cost-utility analysis of imrecoxib compared with celecoxib for patients with osteoarthritis. Annals of Translational Medicine. 9(7). 575–575. 7 indexed citations
9.
Zhen, Xuemei, Cecilia Stålsby Lundborg, Xueshan Sun, et al.. (2021). Economic burden of antibiotic resistance in China: a national level estimate for inpatients. Antimicrobial Resistance and Infection Control. 10(1). 5–5. 68 indexed citations
10.
Gu, Shuyan, Lizheng Shi, Hui Shao, et al.. (2020). Choice across 10 pharmacologic combination strategies for type 2 diabetes: a cost-effectiveness analysis. BMC Medicine. 18(1). 378–378. 12 indexed citations
11.
Hu, Xiaoqian, Shuyan Gu, Xueshan Sun, et al.. (2019). Cognitive ageing trajectories and mortality of Chinese oldest-old. Archives of Gerontology and Geriatrics. 82. 81–87. 29 indexed citations
12.
Gu, Shuyan, Xiaoju Wang, Lizheng Shi, et al.. (2018). Valuing Health-Related Quality of Life for Inpatients with Diabetes-Related Complications In China. Value in Health. 21. S77–S78. 1 indexed citations
13.
Sun, Xueshan, Xiaoqian Hu, Shuyan Gu, et al.. (2018). Measurement and analysis of equity in health: a case study conducted in Zhejiang Province, China. International Journal for Equity in Health. 17(1). 36–36. 21 indexed citations
14.
Zhen, Xuemei, et al.. (2017). The difference in medical costs between carbapenem-resistant Acinetobacter baumannii and non-resistant groups: a case study from a hospital in Zhejiang province, China. European Journal of Clinical Microbiology & Infectious Diseases. 36(10). 1989–1994. 25 indexed citations
15.
Gu, Shuyan, Hui Shao, Yundian Zeng, Lizheng Shi, & Hui Dong. (2016). Cost-Effectiveness of Saxagliptin Versus Acarbose as Second-Line Therapy in Type 2 Diabetes in China. Value in Health. 19(7). A898–A898. 1 indexed citations
16.
Gu, Shuyan, et al.. (2016). Cost-Effectiveness of Saxagliptin versus Acarbose as Second-Line Therapy in Type 2 Diabetes in China. PLoS ONE. 11(11). e0167190–e0167190. 12 indexed citations
17.
Gu, Shuyan & Hui Dong. (2016). Cost-Effectiveness of Dapagliflozin Versus Acarbose as A Monotherapy in Type 2 Diabetes in China. Value in Health. 19(7). A898–A898. 2 indexed citations
18.
Gu, Shuyan, et al.. (2015). Cost-Minimization Analysis of Metformin and Acarbose in Treatment of Type 2 Diabetes. Value in Health Regional Issues. 6. 84–88. 10 indexed citations
20.
Liang, Jersey, James F. McCarthy, Arvind Jain, et al.. (2000). Socioeconomic Gradient in Old Age Mortality in Wuhan, China. The Journals of Gerontology Series B. 55(4). S222–S233. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026